Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dynatrace, Inc.DT · Entity 697 | Director | August 26, 2026 | August 27, 2026 |
| Medidata Solutions, Inc.MDSO · Entity 154211 | Chief Operating Officer | November 15, 2017 | November 17, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dynatrace, Inc.
Report date August 26, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,458 |
Reported balance
After 2026-08-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-26 · Grant · Acquired 4,458 · Balance 4,458 F1: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. F2: Represents the grant of RSUs under the Issuer's 2019 Equity Incentive Plan, as amended, and the Amended and Restated Non-Employee Director Compensation Policy. 100% of the RSUs granted will vest on the earlier of the one year anniversary of the date of grant (August 26, 2027) and the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director of the Issuer on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date.
F2: Represents the grant of RSUs under the Issuer's 2019 Equity Incentive Plan, as amended, and the Amended and Restated Non-Employee Director Compensation Policy. 100% of the RSUs granted will vest on the earlier of the one year anniversary of the date of grant (August 26, 2027) and the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director of the Issuer on the applicable vesting date.
Medidata Solutions, Inc.
Report date November 15, 2017 · Filed November 17, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 155,446 |
Reported balance
After 2017-11-15 transaction · row 1
1 source rowRow 1 · 2017-11-15 · Sale · Disposed 5,000 · Balance 155,446 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2016. F2: Such transaction was executed in multiple trades at prices ranging from $65.53 to $66.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2016.
F2: Such transaction was executed in multiple trades at prices ranging from $65.53 to $66.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2026 Filed Aug 27, 2026 21:30 UTC | Dynatrace, Inc. DT · Entity 697 | GrantRestricted Stock Units · Derivative | 4,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001443483-26-000004 · wk-form4_1787866231.xml · derivative · entry 1 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,458 Underlying: Common Stock · 4,458 shares Expires not disclosed F1 · derivative.exercise_price: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. F2 · derivative.exercise_date: Represents the grant of RSUs under the Issuer's 2019 Equity Incentive Plan, as amended, and the Amended and Restated Non-Employee Director Compensation Policy. 100% of the RSUs granted will vest on the earlier of the one year anniversary of the date of grant (August 26, 2027) and the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director of the Issuer on the applicable vesting date. F1 · derivative.expiration_date: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 21:17 UTC | Dynatrace, Inc. DT · Entity 697 | Exercise / conversionRestricted Stock Units · Derivative | 4,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001443483-26-000002 · wk-form4_1787606238.xml · derivative · entry 2 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,111 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. F2 · derivative.exercise_date: Represents the vesting of RSUs granted on August 20, 2025 under the Issuer's 2019 Equity Incentive Plan, as amended, and the Amended and Restated Non-Employee Director Compensation Policy. 100% of these RSUs vested on August 20, 2026, which was the earlier of the one-year anniversary of the date of grant (August 20, 2026) and the date of the Issuer's 2026 Annual Meeting of Stockholders (scheduled to be held on August 26, 2026). F1 · derivative.expiration_date: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. Read SEC document |
| August 20, 2026 Filed Aug 24, 2026 21:17 UTC | Dynatrace, Inc. DT · Entity 697 | Exercise / conversionCommon Stock | 4,111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001443483-26-000002 · wk-form4_1787606238.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. F1 · price: Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 20:17 UTC | Dynatrace, Inc. DT · Entity 697 | GrantRestricted Stock Units · Derivative | 4,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001773383-25-000172 · wk-form4_1755807430.xml · derivative · entry 5 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,111 Underlying: Common Stock · 4,111 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. F5 · derivative.exercise_date: Represents the grant of RSUs. 100% of the RSUs granted will vest on the earlier of the one year anniversary of the date of grant (August 20, 2026) and the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director of the Issuer on the applicable vesting date. F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 20:17 UTC | Dynatrace, Inc. DT · Entity 697 | Exercise / conversionRestricted Stock Units · Derivative | 3,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001773383-25-000172 · wk-form4_1755807430.xml · derivative · entry 4 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,981 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. F4 · derivative.exercise_date: As previously reported on August 27, 2024, these RSUs were granted on August 23, 2024. 100% of the RSUs granted vested on August 20, 2025, which was the earlier of the one year anniversary of the date of grant (August 23, 2025) and the date of the Issuer's 2025 Annual Meeting of Stockholders (which was held on August 20, 2025). F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 20:17 UTC | Dynatrace, Inc. DT · Entity 697 | Exercise / conversionCommon Stock | 3,981 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773383-25-000172 · wk-form4_1755807430.xml · nonDerivative · entry 2 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 21:44 UTC | Dynatrace, Inc. DT · Entity 697 | GrantCommon Stock | 3,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001773383-24-000178 · wk-form4_1724795039.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,471 F1 · shares: Consists of Restricted Stock Units ("RSUs") granted on August 23, 2024 under the Dynatrace, Inc. 2019 Equity Incentive Plan and the Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock on the earlier of the one-year anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:19 UTC | Dynatrace, Inc. DT · Entity 697 | GrantCommon Stock | 4,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001773383-23-000163 · wf-form4_169299472018306.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,490 F1 · shares: Consists of Restricted Stock Units ("RSUs") granted on August 23, 2023 under the Dynatrace, Inc. 2019 Equity Incentive Plan and the Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock on the earlier of the one-year anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 20:27 UTC | Dynatrace, Inc. DT · Entity 697 | GrantCommon Stock | 5,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001773383-22-000108 · wf-form4_166154561241969.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,200 F1 · shares: Consists of Restricted Stock Units ("RSUs") granted on August 24, 2022 under the Dynatrace, Inc. 2019 Equity Incentive Plan and the Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock on the earlier of the one-year anniversary of the date of grant or on the date of the 2023 Annual Meeting of Stockholders. Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 20:19 UTC | Dynatrace, Inc. DT · Entity 697 | GrantCommon Stock | 3,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001773383-21-000100 · wf-form4_163035475799572.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,010 F1 · shares: Consists of Restricted Stock Units ("RSUs") granted on August 26, 2021 under the Dynatrace, Inc. 2019 Equity Incentive Plan and the Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock on the earlier of the one-year anniversary of the date of grant or on the date of the 2022 Annual Meeting of Stockholders. Read SEC document |
| August 25, 2020 Filed Aug 27, 2020 20:38 UTC | Dynatrace, Inc. DT · Entity 697 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001773383-20-000100 · wf-form4_159856069896963.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · shares: Consists of Restricted Stock Units ("RSUs") granted on August 25, 2020 under the Dynatrace, Inc. 2019 Equity Incentive Plan and the Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock on the earlier of the one-year anniversary of the date of grant or on the date of the 2021 Annual Meeting of Stockholders. Read SEC document |
| July 31, 2019 Filed Aug 2, 2019 22:40 UTC | Dynatrace, Inc. DT · Entity 697 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-020935 · doc4.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · shares: Consists of Restricted Stock Units ("RSUs") issued under the Dynatrace, Inc. 2019 Equity Incentive Plan. Each RSU represents the right to receive one share of Common Stock. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 16:41 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | SaleCommon Stock | 5,000 | $66.33 | $331,650.00 |
DisclosureSEC source: 0001453814-17-000132 · wf-form4_151095489661528.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,446 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2016. F2 · price: Such transaction was executed in multiple trades at prices ranging from $65.53 to $66.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 01, 2017 Filed Oct 2, 2017 16:45 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | Tax withholdingCommon Stock | 6,592 | $78.06 | $514,571.52 |
DisclosureSEC source: 0001453814-17-000117 · wf-form4_150697709701382.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,446 F1 · shares: Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 16:37 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | SaleCommon Stock | 5,000 | $74.53 | $372,650.00 |
DisclosureSEC source: 0001453814-17-000115 · wf-form4_150300222070254.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,038 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2016. F2 · price: Such transaction was executed in multiple trades at prices ranging from $74.05 to $75.32. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Included are 284 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on June 30, 2017. Read SEC document |
| May 15, 2017 Filed May 16, 2017 16:34 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | SaleCommon Stock | 5,000 | $69.46 | $347,300.00 |
DisclosureSEC source: 0001453814-17-000081 · wf-form4_149496686008936.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,754 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2016. F2 · price: Such transaction was executed in multiple trades at prices ranging from $69.35 to $69.50. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 18:29 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | Tax withholdingCommon Stock | 2,873 | $55.60 | $159,738.80 |
DisclosureSEC source: 0001453814-17-000049 · wf-form4_148823816076725.xml · nonDerivative · entry 5 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,754 F4 · shares: Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 18:29 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | Tax withholdingCommon Stock | 8,764 | $55.60 | $487,278.40 |
DisclosureSEC source: 0001453814-17-000049 · wf-form4_148823816076725.xml · nonDerivative · entry 4 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,627 F4 · shares: Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 18:29 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | Tax withholdingCommon Stock | 3,490 | $55.60 | $194,044.00 |
DisclosureSEC source: 0001453814-17-000049 · wf-form4_148823816076725.xml · nonDerivative · entry 3 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,391 F3 · shares: Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of the PBRSU award referenced above. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 18:29 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | Exercise / conversionCommon Stock | 9,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001453814-17-000049 · wf-form4_148823816076725.xml · nonDerivative · entry 2 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,881 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents restricted stock units earned in connection with a performance-based restricted stock unit ("PBRSU") award on February 13, 2015, based on achievement of certain TSR performance targets for the two years ended December 31, 2016. The restricted stock units were settled at 127% of the target grant amount. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 18:29 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | GrantRestricted Stock Units (Performance-Related) · Derivative | 43,186 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001453814-17-000049 · wf-form4_148823816076725.xml · derivative · entry 6 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,186 Underlying: Common Stock · Not disclosed shares Expires not disclosed F5 · derivative.exercise_date: Award of PBRSUs under the 2009 LTIP on February 23, 2017. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2019, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2019. The shares will vest immediately upon being earned. F5 · derivative.expiration_date: Award of PBRSUs under the 2009 LTIP on February 23, 2017. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2019, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2019. The shares will vest immediately upon being earned. F5 · derivative.underlying_shares: Award of PBRSUs under the 2009 LTIP on February 23, 2017. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-200% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2019, and (ii) 50% based on the Company's GAAP Net Income attainment for the three years ending December 31, 2019. The shares will vest immediately upon being earned. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 18:29 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | GrantCommon Stock | 43,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001453814-17-000049 · wf-form4_148823816076725.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,442 F1 · kind: Award of shares of restricted stock under the issuer's Second Amended & Restated 2009 Long-Term Incentive Plan (the "2009 LTIP") on February 23, 2017. The restrictions will lapse with respect to one-fourth of the shares on each of February 23, 2018, February 23, 2019, February 23, 2020, and February 23, 2021. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 17:39 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | SaleCommon Stock | 5,000 | $56.14 | $280,700.00 |
DisclosureSEC source: 0001453814-17-000028 · wf-form4_148719836324236.xml · nonDerivative · entry 2 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,256 F3 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2016. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 17:39 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | Tax withholdingCommon Stock | 2,131 | $56.98 | $121,424.38 |
DisclosureSEC source: 0001453814-17-000028 · wf-form4_148719836324236.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,256 F1 · shares: Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock. F2 · balance_after: Included are 243 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on December 31, 2016. Read SEC document |
| October 01, 2016 Filed Oct 4, 2016 16:43 UTC | Medidata Solutions, Inc. MDSO · Entity 154211 | Tax withholdingCommon Stock | 6,089 | $55.76 | $339,522.64 |
DisclosureSEC source: 0001453814-16-000301 · wf-form4_147561381605903.xml · nonDerivative · entry 1 Capone Michael L · CIK 0001443483 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,144 F1 · shares: Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock. F2 · balance_after: Included are 282 shares which were purchased pursuant to the terms of the Medidata Solutions, Inc. Employee Stock Purchase Plan on June 30, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.